Vein External Support Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01415245

Acronym

VEST

Enrollment

Registered

2011-08-11

Start date

2011-10-31

Completion date

2013-12-31

Last updated

2014-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease

Brief summary

Prospective, multi-center, randomized, controlled pilot study to demonstrate the safety and effectiveness of the VGS Fluent external support device, supporting saphenous vein grafts in patients with coronary heart disease.

Interventions

DEVICEFluent (VGS Fluent external support device)

Fluent external support device applied to saphenous vein graft

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

50 Years to 80 Years

Healthy volunteers

Inclusion criteria

Primary Inclusion Criteria: 1. Patient scheduled for on-pump CABG on clinical grounds 2. Vein grafts indicated for right and circumflex coronary arteries and LIMA indicated for the LAD on clinical grounds 3. Native circumflex and right coronary arteries have at least one stenosis in each vessel\> 75% Primary

Exclusion criteria

1. Concomitant non-CABG cardiac procedure 2. Prior peripheral vascular or cardiac surgery 3. Emergency CABG surgery (cardiogenic shock, inotrophic pressure support, IABP)

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026